🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 13 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/01/2013 | 53,09 | 53,39 | 51,60 | 51,97 | -1,61% | 3,37% | 999.300 |
| 03/01/2013 | 53,54 | 53,81 | 52,56 | 52,82 | -1,88% | 2,33% | 577.800 |
| 02/01/2013 | 54,39 | 54,90 | 53,08 | 53,83 | +0,77% | 3,35% | 1.373.000 |
| 31/12/2012 | 51,75 | 53,76 | 51,75 | 53,42 | +2,45% | 3,88% | 572.900 |
| 28/12/2012 | 52,28 | 52,59 | 52,04 | 52,14 | -0,91% | 1,05% | 324.500 |
| 27/12/2012 | 52,61 | 52,80 | 52,08 | 52,62 | +0,57% | 1,37% | 413.900 |
| 26/12/2012 | 52,55 | 52,74 | 51,91 | 52,32 | -0,42% | 1,58% | 434.800 |
| 24/12/2012 | 52,39 | 52,67 | 51,98 | 52,54 | +0,06% | 1,32% | 241.500 |
| 21/12/2012 | 52,50 | 52,53 | 50,88 | 52,51 | +0,11% | 3,14% | 1.252.200 |
| 20/12/2012 | 51,64 | 52,50 | 51,53 | 52,45 | +1,86% | 1,88% | 581.300 |
| 19/12/2012 | 51,72 | 51,92 | 51,19 | 51,49 | -0,52% | 1,41% | 423.400 |
| 18/12/2012 | 50,87 | 51,87 | 50,74 | 51,76 | +2,15% | 2,22% | 410.800 |
| 17/12/2012 | 50,44 | 50,78 | 50,06 | 50,67 | +0,58% | 1,43% | 439.200 |
| 14/12/2012 | 50,28 | 50,98 | 50,05 | 50,38 | +0,24% | 1,85% | 631.500 |
| 13/12/2012 | 50,68 | 51,22 | 49,55 | 50,26 | -3,64% | 3,30% | 1.166.600 |
| 12/12/2012 | 52,97 | 53,19 | 51,62 | 52,16 | -1,47% | 2,96% | 605.000 |
| 11/12/2012 | 52,32 | 53,00 | 52,12 | 52,94 | +2,00% | 1,68% | 476.200 |
| 10/12/2012 | 52,02 | 52,81 | 51,76 | 51,90 | -0,27% | 2,02% | 491.100 |
| 07/12/2012 | 52,46 | 52,49 | 51,56 | 52,04 | -0,38% | 1,77% | 356.800 |
| 06/12/2012 | 52,56 | 53,27 | 52,16 | 52,24 | -0,23% | 2,11% | 514.700 |
| 05/12/2012 | 52,77 | 52,85 | 51,42 | 52,36 | -0,40% | 2,71% | 760.700 |
| 04/12/2012 | 52,54 | 52,99 | 52,17 | 52,57 | -0,13% | 1,56% | 714.700 |
| 03/12/2012 | 52,80 | 52,93 | 52,19 | 52,64 | +0,17% | 1,40% | 320.500 |
| 30/11/2012 | 53,16 | 53,48 | 52,20 | 52,55 | -0,81% | 2,41% | 522.700 |
| 29/11/2012 | 52,24 | 53,00 | 52,04 | 52,98 | +1,90% | 1,84% | 431.900 |
| 28/11/2012 | 52,48 | 52,48 | 50,78 | 51,99 | -1,20% | 3,24% | 812.700 |
| 27/11/2012 | 54,00 | 54,23 | 52,43 | 52,62 | -2,47% | 3,33% | 1.013.200 |
| 26/11/2012 | 53,40 | 54,00 | 52,89 | 53,95 | +0,78% | 2,08% | 1.013.500 |
| 23/11/2012 | 52,64 | 53,57 | 52,39 | 53,53 | +2,04% | 2,24% | 291.800 |
| 21/11/2012 | 51,38 | 52,50 | 51,13 | 52,46 | +2,12% | 2,67% | 771.600 |